Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) , relating to the proposed merger with Johnson & Johnson. Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of ...
Benchmark analysts maintained a Buy rating on Amplify Energy Corp. (NYSE:AMPY) with a price target of $11.00. According to ...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Amplify Energy Corp. (NYSE: AMPY) and ...
Alliance Global Partners analyst Jeff Grampp reiterated a Buy rating on Amplify Energy (AMPY – Research Report) today and set a price target of ...
Amplify Energy (AMPY) has entered into a definitive merger agreement with privately held Juniper Capital to combine with ...